Tag: Jaala Pulford
Australian medtech, pharma industries get boost in 2023 Federal Budget
The Federal government has allocated $392.4 million in funding for the establishment of a new Industry Growth Program that would boost the development of priority sectors, such as medtech, biotech, and pharma.
BioNTech to empower Vic with new mRNA R&D centre
German biotechnology manufacturer BioNTech has selected Victoria to house its Asia-Pacific mRNA clinical research and development centre.
Victorian researcher sought for new Pfizer mRNA fellowship program
The Victorian government is backing a fellowship that will support a Victorian researcher to work at Pfizer’s Emerging Science and Innovation Unit RNA Accelerator in the United States in 2023.
Vic announces funding for new medtech innovation & commercialisation centre
The Victorian government has announced $2.4 million in funding to establish the Victorian Connected Health Innovation and Commercialisation Centre in Melbourne’s central business district.
Made...
Victoria spearheads world-first mRNA research collaboration with new innovation hub
The Victorian government is continuing its commitment to boosting mRNA in a new collaboration with the state’s biggest research institutions, a first-of-its-kind partnership in...
Victoria unveils 10-year strategy to accelerate health and medical research sector
The Victorian government has launched a 10-year plan that seeks to ensure the state is equipped with the workforce, institutions, and scientific innovations needed...
US biotech firm Ginkgo Bioworks opens new hub in Melbourne
Ginkgo Bioworks, a US-based biotech company, has moved into its new office in Melbourne, which will serve as its new base for Australia and...
A step closer to Greater Geelong Convention Centre
The Victorian Government and Deakin University are planning to have a joint vision to develop opportunities and deliver jobs with a new Geelong Action...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
